Skip to main content
Equibles

ADAGE CAPITAL PARTNERS GP, L.L.C.

Position in KPTI — Karyopharm Therapeutics Inc.

CIK 1165408 Boston, MA
Back to KPTI Full portfolio

Position in KPTI

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$14,863,315
+$4,802,102 QoQ
Shares Held
1,521,322
-15.8% QoQ
Ownership
6.71%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#2
of 96 holders
Holding Since
Mar 2020
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in KPTI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 125 Biotechnology names. KPTI ranks #67 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ROIV
Roivant Sciences Ltd.
 10,349,328 $366,262,717
2 PRAX
Praxis Precision Medicines, Inc.
 1,015,480 $339,972,549
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 393,964 $195,693,737
4 TNGX
Tango Therapeutics, Inc.
 5,600,000 $175,056,000
5 BBIO
BridgeBio Pharma, Inc.
 2,252,000 $167,728,960
6 SYRE
Spyre Therapeutics, Inc.
 1,722,300 $152,905,794
7 TVTX
Travere Therapeutics, Inc.
 2,569,356 $145,965,114
8 RPRX
Royalty Pharma plc
 2,500,000 $140,175,000

All Filings in KPTI

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,863,315 1,521,322
2026-03-31 $10,061,213 1,806,322
2025-12-31 $3,100,929 421,322
2025-09-30 $2,755,445 421,322
2025-06-30 $1,815,897 421,322
2025-03-31 $1,575,744 421,322
2024-12-31 $4,272,213 6,319,842
2024-09-30 $3,585,468 4,319,842
2024-06-30 $3,749,622 4,319,842
2024-03-31 $5,285,000 3,500,000
2023-12-31 $1,438,754 1,663,300
2022-12-31 $2,620,424 770,713
2021-03-31 $14,199,896 1,349,800
2020-12-31 $38,158,200 2,465,000
2020-09-30 $46,908,792 3,212,931
2020-06-30 $61,531,116 3,248,739
2020-03-31 $71,529,049 3,723,532